SCHEMBL2184509

SCHEMBL2184509

O=[N+]([O-])c1ccccc1S(=O)(=O)F

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 5/20 0.70
▸ MEN1 O00255 4/20 0.70
▸ CA1 P00915 1/20 0.59
▸ CA2 P00918 1/20 0.59
▸ MMP1 P03956 1/20 0.59
▸ MMP2 P08253 1/20 0.59
▸ MMP9 P14780 1/20 0.59
▸ MMP8 P22894 1/20 0.59
▸ MMP13 P45452 1/20 0.59
▸ F2 P00734 2/20 0.54
▸ PRSS1 P07477 2/20 0.54
▸ PRSS2 P07478 2/20 0.54
▸ PRSS3 P35030 2/20 0.54
▸ ALDH1A1 P00352 1/20 0.53
▸ GAA P10253 1/20 0.50
▸ LMNA P02545 1/20 0.50
▸ THRB P10828 1/20 0.50
▸ CYP19A1 P11511 1/20 0.49
▸ PKM P14618 1/20 0.49
▸ TDP1 Q9NUW8 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31251161 1.00 KMT2A (0.70) KMT2AMEN1CA1CA2MMP1
SCHEMBL8419869 0.85 KMT2A (0.67) KMT2AMEN1CA1CA2MMP1
SCHEMBL30446303 0.83 KMT2A (1.00) KMT2AMEN1CA1CA2MMP1
SCHEMBL2039879 0.83 KMT2A (1.00) KMT2AMEN1CA1CA2MMP1
SCHEMBL11566827 0.83 KMT2A (1.00) KMT2AMEN1CA1CA2MMP1
SCHEMBL31294149 0.82 KMT2A (0.53) KMT2AMEN1CA1CA2MMP1
SCHEMBL237684 0.81 KMT2A (0.73) KMT2AMEN1CA1CA2MMP1
SCHEMBL1148394 0.79 KMT2A (0.70) KMT2AMEN1CA1CA2MMP1
SCHEMBL1498160 0.79 KMT2A (0.70) KMT2AMEN1CA1CA2MMP1
SCHEMBL63933 0.79 KMT2A (0.70) KMT2AMEN1CA1CA2MMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 612 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4740438-A1 METHOD AND SYSTEM FOR MANAGING MESSAGES IN BINDING SUPPORT FUNCTION BSF UNIT OF COMMUNICATION NETWORK Jio Platforms Limited (IN) 2026-05-13 — — EP claimed
US-12452146-B2 Supporting multiple application function sessions with required group quality of service (QoS) provided by machine learning model provider application function INTEL CORPORATION (US) 2025-10-21 — — US claimed
US-20250112973-A1 ROUTING OF 4G AND 5G SESSIONS ORACLE INTERNATIONAL CORPORATION 2025-04-03 — — US claimed
WO-2025012927-A1 METHOD AND SYSTEM FOR MANAGING MESSAGES IN BINDING SUPPORT FUNCTION BSF UNIT OF COMMUNICATION NETWORK Jio Platforms Limited (IN) 2025-01-16 — — WO claimed
CN-118825931-A NBSF sequence control method, device, equipment and storage medium 国网江苏省电力有限公司超高压分公司 2024-10-22 — — CN claimed
CN-118648366-A Communication method and device, communication equipment, communication system and storage medium 北京小米移动软件有限公司 2024-09-13 — — CN claimed
CN-117528480-A Binding information processing method, BSF entity, communication system and storage medium 中国电信股份有限公司 2024-02-06 — — CN claimed
US-20230199868-A1 POLICY ENHANCEMENT TO SUPPORT GROUP APPLICATION FUNCTION (AF) SESSION FROM ARTIFICIAL INTELLIGENCE/MACHINE LEARNING (AIML) PROVIDER AF WITH REQUIRED QUALITY OF SERVICE (QOS) INTEL CORPORATION 2023-06-22 — — US claimed
US-20230171168-A1 SUPPORTING MULTIPLE APPLICATION FUNCTION SESSIONS WITH REQUIRED GROUP QUALITY OF SERVICE (QOS) PROVIDED BY MACHINE LEARNING MODEL PROVIDER APPLICATION FUNCTION INTEL CORPORATION 2023-06-01 — — US claimed
US-20230097876-A1 APPARATUS AND METHOD FOR SUPPORTING UPF EVENT EXPOSURE SERVICE IN WIRELESS COMMUNICATION SYSTEM SAMSUNG ELECTRONICS CO., LTD. (KR) 2023-03-30 — — US claimed
CN-111935738-B Method and system for multi-operator core network docking MEC 网络通信与安全紫金山实验室 2022-07-26 — — CN claimed
EP-2866029-A1 METHOD FOR PREPARING SAMPLE CONTAINING PANCREATIC JUICE COMPONENT, AND KIT FOR STORING BIOLOGICAL SAMPLE CONTAINING PANCREATIC JUICE COMPONENT AT ROOM TEMPERATURE Olympus Corporation (JP) 2015-04-29 — — EP claimed
EP-2757151-A1 METHOD FOR INHIBITING PROTEASE IN BIOLOGICAL SAMPLE CONTAINING PANCREATIC JUICE COMPONENT Olympus Corporation (JP) 2014-07-23 — — EP claimed
US-20140186869-A1 METHOD FOR INHIBITING PROTEASE IN BIOLOGICAL SAMPLE CONTAINING PANCREATIC JUICE COMPONENTS OLYMPUS CORPORATION (JP) 2014-07-03 — — US claimed
EP-4747746-A1 SYSTEM AND METHOD FOR TROUBLESHOOTING USING ERROR LOGS IN A NETWORK Jio Platforms Limited (IN) 2026-05-27 — — EP disclosed
EP-4747770-A1 SYSTEM AND METHOD FOR DYNAMIC COMPARISON OF VALUES IN BUSINESS RULE ENGINE Jio Platforms Limited (IN) 2026-05-27 — — EP disclosed
EP-4748066-A1 SYSTEM AND METHOD FOR MANAGING SUBSCRIBER PROFILES IN A NETWORK Jio Platforms Limited (IN) 2026-05-27 — — EP disclosed
US-4060549-A Process for preparing sulfonic acid fluorides BAYER AKTIENGESELLSCHAFT (DT) 1977-11-29 — — US disclosed
US-4042586-A ADRENERGIC BLOCKING AGENTS MERCK SHARP & DOHME (I.A.) CORPORATION (US) 1977-08-16 — — US disclosed
US-3946009-A ADRENERGIC BLOCKING AGENTS MERCK SHARP & DOHME (I.A.) CORPORATION (US) 1976-03-23 — — US disclosed
Send feedback